GRI Index 2020

GRI Standard Disclosure 2020 Response
GRI 100: Universal Standards Series
General Disclosure
GRI 102: General Disclosures
Organizational Profile
102-1 – Name of the organization LifeLabs LP
102-2 – Activities, brands, products, and services About Us 
102-3 – Location of headquarters Contact Us (Offices and Main Labs)
102-4 – Location of operations Proudly serving British Columbia, Ontario and Saskatchewan
102-5 – Ownership and legal form About Us 
102-6 – Markets served Proudly serving communities in British Columbia, Ontario, and Saskatchewan, LifeLabs has experience in serving long-term care facilities every year, in addition to serving patients daily through our homecare and mobile visits. We have developed partnerships and reference testing for hospitals, and support thousand of health care providers. 
102-7 – Scale of the organization
  • 375 centres providing service across Canada
  • 16 LifeLabs laboratories
  • Performed over 99 million laboratory tests in 2020
  • 72,300 patient visits per day
  • Two Genetic laboratories
102-8 – Total number of employees by employment contract (permanent and temporary) by gender and region

Total number of employees by employment contract (permanent and temporary) by gender:

  • Female: permanent = 4,503, temporary = 504
  • Male: permanent = 1,330, temporary = 127

Total number of employees by employment contract (permanent and temporary) by region:

  • Permanent: AB = 5, BC = 1,712, ON = 3,973, SK = 143
  • Temporary: AB = 2, BC = 349, ON = 259, SK = 21

Total number of employees by employment type (full-time and part-time) by gender:

  • Female: full-time = 2,445, part-time = 2,058, casual = 173, temporary = 331
  • Male: full-time = 802, part-time = 528, casual = 60, temporary = 67
102-9 – Supply chain LifeLabs has a complex supply chain involving relationships with numerous suppliers, manufacturers and distributors in areas such as laboratory equipment, consumables, business services, goods for our operations and more. We leverage the expertise of our Quality & Regulatory Assurance, Employee Health & Safety and Environmental departments on all major procurements for assessments of risks in these areas. 
102-10 – Significant changes to the organization and its supply chain There were no material changes in Procurement in 2020 as an organization
102-13 – Membership of associations
  • Canadian Society of Medical Laboratory Sciences
  • BC Business Council
  • Greater Vancouver Board of Trade
  • Saskatchewan Chamber of Commerce
  • Ontario Association of Medical Laboratories
  • Toronto Board of Trade
  • Burnaby Board of Trade
  • LifeSciences BC
  • Ontario Chamber of Commerce
  • Digital Health Canada
  • C.D. Howe
Ethics & Integrity
102-16 – Values, principles, standards, and norms of behavior LifeLabs is committed to building a culture based on our core values that are grounded in integrity, mutual respect and trust. The Code of Conduct has also been developed to lend support to our vision of “Building a Healthier Canada” and to help guide us in living our values of “Caring, One Team, Agile and Customer Driven” – every day, everywhere in the business. This Code is a guide to assist everyone at LifeLabs in making the right business decisions. It sets out principles that govern the way we carry on business, provides clarity about expectations at LifeLabs, and identifies other LifeLabs resources and policies that you can use to support decision making.
102-17 – Mechanisms for advice and concerns about ethics Since April 2018, LifeLabs has maintained a Whistleblower program This program is intended to encourage employees to raise serious concerns they may have around issues of compliance with Code of Conduct, applicable laws, rules, regulations and our policies where those concerns have not been adequately addressed through regular channels employees can make an anonymous report by telephone, through a dedicated website, or by mail, via our third party provider, ClearView Connects.
102-18 – Governance structure About Us: Leadership – link to (/about-us/leadership/)
102-19 – Delegating authority Responsibility for reporting on sustainability has been delegated to the Director of Health & Safety and Environmental Sustainability. 
102-22 – Composition of the highest governance body and its committees
  • Non-Executive: 90%
  • Executive: 10%
  • Independent directors: 33%
  • Average Tenure: 3 years
  • Male: 67%
  • Female: 33%
102-23 – Chair of the highest government body The Chair of the Board and the Chief Executive Officer of LifeLabs are separate roles.
102-24 – Nominating and selecting the highest governance body LifeLabs is controlled by a sole shareholder (the “Shareholder”) and the Board is comprised of directors appointed by the Shareholder. 
102-25 – conflicts of interest The Shareholder requires prospective Board members to complete a Conflict of Interest declaration prior to appointment to the Board.
Stakeholder Engagement
102-40 – List of stakeholder groups  
Engaging and collaborating with our stakeholders is a key input to the development of our material topics and Sustainability Strategy at LifeLabs. We are committed to working toward amplifying our disclosure on stakeholder engagement in our future reports. 
102-41 – Collective bargaining agreements
  • Non-Union employees: 4,933 (75.3%)
  • Union employees: 1,618 (24.7%)
102-42 – Identifying and selecting stakeholders We do not have a formal process for stakeholder engagement however, we are in the process of developing a plan to work toward amplifying our disclosure on stakeholder engagement in our future reports.
Reporting Practice
102-48 – Restatements of information Every effort is made to ensure that we report accurate data, and our processes are designed to support this. In cases where we become aware of updates to data from previous years, we consider providing updated data if the changes result in a discrepancy that is material to our reporting.
102-50 – Reporting period This report covers data and progress from the calendar year 2020, unless otherwise stated, from our operations.
102-51 – Date of most recent report /global-reporting-initiative-gri/
102-52 – Reporting cycle  
We plan to continue to report on an annual basis. 
102-53 – Contact point for questions regarding the report
102-54 – Claims of reporting in accordance with the GRI Standards  
Our 2020 report has been prepared in reference to the Global Reporting Initiative (GRI) Standards and includes a GRI Content Index focused on topics that the organization is actively engaged in supporting. As we grow our sustainability initiatives, so too will the depth of our reporting.
102-55 – GRI Content Index  GRI Content Index
GRI 200: Economic Performance Standard Series
Market Presence
GRI 202: Market Presence 
202-1 – Ratios of standard entry level wage by gender compared to local minimum wage Wages at LifeLabs are not defined based on gender and comply with all provincial legislation related to pay. Our pay is established based on our internal job evaluation system, which groups similar roles based on the skill, effort, responsibility and working conditions, and the external market for each position. This system ensures that pay decisions are free from any deliberate or systemic gender bias.
202-2 – Proportion of senior management hired from the local community For roles which are regionally or provincially focused, LifeLabs hires qualified candidates from the local community. For roles with company-wide (national) accountability, the most qualified candidate is selected. In most cases, the candidate is not asked to relocate.
Indirect Economic Impacts
GRI 203: Indirect Economic Impacts 
203-1 – Infrastructure investments and services supported

As a result of the COVID-19 pandemic, LifeLabs’ community investment efforts were temporarily paused as our non-profit partners adjusted to the new environment. Nevertheless, LifeLabs and its employees were proud to donate over $25,000 to 57 different organizations.

LifeLabs Employees Donated: $18,021
Employee Giving Program Match: $7,791
Community Investment National: $60,000 – /lifelabs-raises-over-60000-in-support-of-children-with-cancer/

Procurement Practices
GRI 204: Procurement Practices 
204-1 – Proportion of spending on local suppliers LifeLabs does have a formal policy indicating a preference for local suppliers. In 2020, 80% of our purchases were from Canadian suppliers and distributors.
GRI 205: Anti-corruption 
205-2 – Communication and training about anti-corruption policies and procedures The LifeLabs Code of Conduct, Conflict of Interest Policy and Whistleblower Policy applies to all LifeLabs officers and employees. It also extends to other parties acting on behalf of LifeLabs such as consultants, the Board of Directors, or other representatives of LifeLabs. A review of LifeLabs Code of Conduct, Conflict of Interest Policy and Whistleblower Policy is included in the orientation plan for all new employees.
GRI 302: Energy
302-1 – Energy consumption within the organization
  • 13,585,917 kWh of electricity was consumed in 2020 at LifeLabs’ four main laboratories (Burnaby, Surrey, Toronto, Mississauga).
  • 383,669 m3 of natural gas was consumed in 2020 at LifeLabs’ four main laboratories (Burnaby, Surrey, Toronto, Mississauga).
302-5 – Reductions in energy requirements of products and services

In 2020, we conducted two energy audits at two laboratories British Columbia to identify opportunities for reductions in energy consumption. A series of recommendations of modifications has been created and will be implemented in the coming years.
There has been a decrease in energy of 250,530 KWh when measuring our 4 main labs. Electricity use is determined through invoice monitoring from local utilities.


Water & Effluent 
GRI 303: Water & Effluent 
303-1 – Interactions with water as a shared resource Wastewater is either discharged to sanitary sewer and treated downstream through municipal water treatment, treated in our ozone treatment systems, or disposed of as hazardous waste. Water management at LifeLabs is an important issue because laboratory testing and equipment require large volumes of water. We are committed to reducing our consumption of natural resources, including water, and reducing the amount of pollution generated by our environmental policy.
303-2 – Management of water discharge-related impacts In addition to comments in 303-1, Wastewater is collected and analyzed for due diligence purposes and compared to municipal guidelines at our major labs. We had no regulatory violations, orders or fines for wastewater discharge issues. 
303-3- Water Withdrawal  
In 2020, our main laboratories (Burnaby, Surrey, Toronto, Mississauga) withdrew 65,098 m3 of water from third-party municipal sources. Withdrawals did not occur from areas in which are water stressed. Water quality is measured on a monthly basis and continues to meet all provincial, regional, and federal requirements.
303-4 – Water Discharge  
In 2020, our main laboratories (Burnaby, Surrey, Toronto, Mississauga) discharged 65,098 m3 of water into third-party municipal sources. Discharges did not occur from areas in which are water stressed. 
303-5- Water Consumption Although water is used in LifeLabs operations it is estimated that water withdrawn is equal to water discharged. We consider water used in cafeterias and by staff as negligible.
GRI 305: Emissions
305-1 – Direct (Scope 1) GHG emissions
  • Road (courier) mileage: 21,458,389 km
  • Road (courier) CO2 emissions: 4592 tonnes
  • Water CO2 emissions: 22 tonnes
  • Electricity CO2 emissions: 285 tonnes
  • Fuel (NG) CO2 emissions: 576 tonnes
  • CO2 emissions are based on the most current and up to date emission factors and may change annually.
305-3 – Other indirect (Scope 3) GHG emissions

Scope 3 business travel sources include air travel.

  • Air mileage: 335,215 km
  • Air CO2 emissions: 59.7 tonnes
  • Non-hazardous waste CO2 emissions: -737 tonnes
  • Hazardous waste CO2 emissions: 1544 tonnes
  • Total waste CO2 emissions (haz+nonhaz): 807 tonnes

CO2 emissions are based on the most current and up to date emission factors and may change annually.

GRI 306: Waste 
306-1 – Waste generation and significant waste-related impacts Activities that generate waste at LifeLabs includes the analysis of laboratory samples for diagnostic purposes resulting in a large volume of chemical and biohazardous waste. The downstream impacts of the organization’s waste stream are mitigated through source elimination, reuse, separation, recycling, and energy recovery where possible.
306-2 – Management of significant waste-related impacts

To limit the waste generated at LifeLabs, we diligently work with our suppliers and internal teams to reduce the amount of waste up- and downstream. Where possible, waste is reused, reduced, recycled, or donated to limit the amount landfilled.

Hazardous and non-hazardous waste is managed through third party vendors and managed off-site. All waste is collected from waste summaries provided by vendors and through invoices. Data is stored in third party online databases, and monitored on a monthly basis for trends, discrepancies, and anomalies.

306-3 – Waste Generated

LifeLabs generated a total of 1,335,409 kg of waste in 2020 at our four main laboratories (Burnaby, Surrey, Toronto, Mississauga). Data has been compiled from waste summaries provided by vendors and through invoices.

  • Recycle: 313,176 kg
  • Compost: 25,022 kg
  • Landfill: 271,793 kg
  • Biohazardous: 626,780 kg
  • Chemical: 98,638 kg
306-4 – Waste Diverted
  • Total weight of diverted waste: 338, 198 kg
  • Total weight of diverted non-hazardous waste: 338, 198 kg

All hazardous waste is managed according to regulatory standards, and is either incinerated with energy recovery or landfilled. All waste is managed off-site with 3rd party vendors. Data has been compiled from waste summaries provided by vendors and through invoices. 

306-5 – Waste directed to disposal
  • Total weight of landfilled waste: 997,211 kg
  • Total weight of landfilled hazardous waste: 725,418 kg
  • Total weight of landfilled non-hazardous waste: 271,793 kg

All hazardous waste is managed according to regulatory standards, and is either incinerated with energy recovery or landfilled. All waste is managed off-site with 3rd party vendors. Data has been compiled from waste summaries provided by vendors and through invoices. 

Environmental Compliance
GRI 307: Environmental Compliance 
307-1 – Non-compliance with environmental laws and regulations LifeLabs commits to fully complying with all applicable environmental regulations at the federal, provincial and municipal levels. We did not receive any fines or orders for environmental non-compliance in 2020. 
Supplier Environmental Assessment 
GRI 308: Supplier Environmental Assessment 
308-1 – New suppliers that were screened using environmental criteria LifeLabs does not report specific numbers or percentages related to environmental screening, however our procurement processes do include specific environmental criteria against which all major equipment and consumable purchases are assessed.
Labour Management Relations
GRI 402: Labour Management Relations
402-1 – Minimum notice periods regarding operational changes LifeLabs complies with relevant local and national laws and any applicable contractual requirements regarding providing notice of significant operational changes.
Occupational Health & Safety
GRI 403: Occupational Health & Safety
403-1 – Workers representation in formal joint management-worker health and safety committees

Occupational health and safety management system elements have been implemented that meet the Occupational Health and Safety Act and Occupational Health and Safety Regulations of BC, SK, and ON. The occupational health and safety management system applies to all LIfeLabs employees, to employees conducting work at workplaces not under our control, and to contractors who come on site at our workplaces. LifeLabs has an internal Environment, Health & Safety Team of professionals to responsible for the management system elements. The occupational health and safety system is not based on a formal management system standard.

The occupational health and safety management system elements applies to all employees across the organization within our own workplaces e.g. our offices, laboratories and patient service centres; to employees who perform work at workplaces not under our control e.g. Mobile Lab Patient Technicians who perform phlebotomy at Long Term Care homes, couriers who pick up specimens from hospitals and physician offices; and to workers who are not employees but perform work at our worksites e.g. facility contractors and laboratory equipment service technicians.

403-2 – Hazard identification, risk assessment, and incident investigation

LifeLabs conducts risk assessments to review current and newly proposed projects and processes. The processes are broken down step by step to identify hazards, assess the severity and frequency of risks, and identify controls to reduce unacceptable health and safety risks. The hierarchy of controls is followed to reduce risks and develop control recommendations. Depending on the processes being evaluated, risk assessments take the form of a 5×5 matrix of severity and frequency, and by assessing risk using Failure Mode Effects Analysis using a 3×10 matrix to assess severity, frequency, and detection of potential failure modes. Risk assessment teams are assembled and depending on the nature of the process or project being assessed will include subject matter experts from operations, the Occupational Health and Safety team, and other support functions like Quality and Regulatory affairs, Medical Sciences, Facilities, Privacy, and IT. Recommendations and additional controls are implemented when needs are identified to reduce health and safety risks.

LifeLabs has an online system for reporting of workplace hazards (and incidents). The online hazard reporting system is accessible through a link from the homepage of the LifeLabs intranet. Supervisors investigate and implement corrective actions for the hazard reports they receive. Another way for workers to report hazards is through the monthly inspections that are conducted at the worksites. Monthly inspections are conducted by Health and Safety Reps or Joint Health and Safety Committee members, and hazards and deficiencies are documented and corrective actions are implemented to eliminate or control the risks from the hazards. Workers are encouraged to report hazards as the organization promotes hazard reporting as a way address hazards before the hazard can injure someone. Workers have the right to refuse work they believe to be unsafe and the organization has a procedure and form for workers to report unsafe work, for supervisors to investigate, for employee health and safety representatives or Joint Health and Safety Committee members to participate in the investigation, and to involve provincial health and safety regulatory officers if required. Workers are protected against reprisals as part of the provincial Workers Compensation Act and a statement that reprisals are prohibited is specified within LifeLabs procedures.

Work related incidents are reported through an online reporting system. The incidents are investigated by supervisors to identify root cause and corrective actions to prevent re-occurrence. Investigations are documented on the online system. Hazards, incidents, and audit results are reviewed by the Health and Safety team and relevant information is shared back with the organization in the form of reminders, alerts, and safety talks.

403-3 – Occupational health services LifeLabs has an internal Environment, Health and Safety team made of safety professionals that provide advice and guidance to the organization to reduce health and safety risks. The Environment, Health and Safety team reviews and undertakes continual improvement of the health and safety programs and procedures for health and safety training, chemical and biological safety, ergonomic hazards, equipment & electrical safety, personal protective equipment, Transportation of Dangerous Goods, facilitation and training of Joint Health and Safety Committees and Employee Health and Safety representatives, Violence Prevention, inspections, risk assessments, hazard and incident reporting, and emergency response and preparedness.
403-4 – Worker participation, consultation, and communication on
occupational health and safety

Workers participate in the occupational health and safety management system through their participation as Health and Safety representatives and through the Joint Health and Safety Committees. Each year, Health and Safety representatives and Joint Health and Safety Committee members are emailed sections of the health and safety programs and their feedback is requested for ideas for improving the programs. Any worker can also email the health and safety team at the email to ask questions and suggest improvements to the program. The safety program also has a document/form that workers can complete to send feedback to the Health and Safety team.

LifeLabs has two “Employee Councils” (one in BC and one in ON) with the mandate to work in partnership with employees across the business, organizational leaders and Human Resources with the goal of contributing to make LifeLabs a great place to work. This is done by:

  • Facilitating dialogue between employees and management
  • Encouraging employees to express their ideas and opinions
  • Openly communicating with respect and professionalism
  • Creating opportunities for all employees to provide input into initiatives that impact the organization

Employee Health and Safety is an important topic for Employee Council

Occupational health and safety information is accessed and communicated through a number of mechanisms

  • Online learning management system includes health and safety modules
  • Safety programs are housed online in ‘Paradigm’, which is a controlled online document database
  • Health and Safety has its own webpages of information accessible on the company’s intranet pages
  • The Safety Data Sheet database is accessible online from any LifeLabs computer
  • Health and Safety articles are shared through the award winning Leaders Digest which provides information to leaders at all levels, through the OneWeekly which is a weekly company newsletter, and through direct emails to staff and to Health and Safety representatives and Joint Health and Safety Committee members
  • Annual health and safety training sessions are held for the health and safety representatives and joint health and safety committee members to attend across BC, SK and ON
403-b – Joint management – worker health and safety committees details

The joint health and safety committees at LifeLabs adhere to their respective provincial regulatory requirements.

The responsibilities include:

  • Represent employees and ensure employees’ participation in EHS at the workplace with the goal to prevent workplace incidents and improve workplace health and safety.
  • Identify occupational hazards. Make recommendations to management/employer to improve workplace health & safety using the LifeLabs EHS Recommendation Form
  • Review, at least annually or more frequently if changes occur in the workplace, the EHS Program (SOPs & Training). Make recommendations to improve the EHS Program using the LifeLabs EHS Recommendation Form.
  • Receive employees’ health & safety concerns/suggestions and discuss issues/suggestions with workplace parties. Recommend solutions reporting locally to Managers, or to EHS, if any.
  • Conduct monthly EHS Audits.
  • Monitor effectiveness of the EHS Program (SOPs) and Training.
  • Investigate work refusals
  • Investigate workplace incidents that may result in critical injuries or a fatality
  • Be present at the beginning of workplace health and safety testing.

All workers are represented either through their Joint Health and Safety Committee or by their Health and Safety Representative, depending on the size of their worksite.

Joint Health and Safety committees meet at a frequency determined by their provincial requirements, either monthly or quarterly at a minimum. Joint Health and Safety committees are an advisory committee and provide recommendations to health and safety in the workplace.

403-5 – Worker training on occupational health and safety Workers complete online education modules on the health and safety programs and read through the health and safety standard operating procedures applicable to their roles. Each business unit includes health and safety orientation for new employees relevant to their business function. Training is delivered through a combination of online training and in-person training depending on the site and business unit. Depending on the training program and a worker’s role, training is taken at the beginning of employment and some courses are set up to be taken as refreshers. Online courses have knowledge check questions and competency quizzes that must be completed to ensure knowledge transfer. 
403-6 – Promotion of worker health

Benefits are an important part of our employees’ Total Rewards package at LifeLabs. Our offering is competitive with the industry, and can include Extended Health Care, Out-of-Country, Dental Care, Basic Life and AD&D, Short Term Disability, Long Term Disability, Critical Illness, Optional Life & AD&D, and covers over 85% of employees (full-time and regular part-time employees).

We have a robust wellness program that includes a wealth of resources and programs that are built around three pillars to address the total well-being of our employees (financial, physical, and emotional). Here are some examples of the offerings under each pillar:

  • Financial – industry-leading retirement investments that are managed by trusted experts, access to financial advice/supports in a confidential setting, and preferred pricing on a variety of services and goods from our ‘perks’ vendors
  • Physical – competitive benefits, plus exclusive access to a variety of services with special discount offers to help employees manage their current health status, and also take a proactive approach to their health and well-being with services around fitness, lifestyle, nutrition and more
  • Emotional – supports to help our employees manage their mental health and wellness, achieve a sense of work-life balance, or get recognized by their team at work and in the community.

These services and programs are easily accessed by employees directly from our vendor platforms, and are heavily promoted through our regular communications channels so they are aware of what’s available.

We have detailed legal agreements in place with all of our partners providing the above offerings, that align with LifeLabs’ information security, privacy, and legal policies. The terms and conditions outlined in said agreements, as well as thorough vendor assessments completed, ensures the confidentiality and protection of our employees’ personal health-related information.

403-7 – Prevention and mitigation of occupational health and safety impacts directly linked by business relationships Health and safety risks, expectations, and requirements are built directly into the procurement process as we work with different business partners. New business services and equipment are reviewed for health and safety risks as part of the selection process.
403-8 – Workers covered by an occupational health and safety management system Occupational health and safety management system elements have been implemented that meet the Occupational Health and Safety Act and Occupational Health and Safety Regulations of BC, SK, and ON. The occupational health and safety system is not based on a formal management system standard. The health and safety system elements applies to all LifeLabs employees and to contractors who’s workplace is controlled by the organization.
403-9 – Work related injuries

In 2020, LifeLabs employees has had 0 fatalities and 0 cases of high-consequence work related injuries.

The recordable work-related injury rate for 2020 was 3.42 and there were 146 recordable work-related injuries. The injury rate is based on the OSHA incident rate formula based on 200,000 hours worked. In 2020 there were 8,535,296 worked hours.

In contrast to the provincial Workers Compensation Boards calculation of hours based on total payroll and average pay per hour which would overestimate the number of hours where employees are at risk of injury (e.g. by including the entire payroll which includes vacation pay, statutory holiday pay, sick pay, leaves), our hours worked methodology for calculating hours refines the hours worked to include those hours where an employee is at risk of injury and conducting work for the organization (e.g. worked hours, training hours, education hours).

Top three injury types were needle sticks (24%), and slips/trips/falls (23%), and ergonomics (22%)

403-10 – Work-related ill health

In 2020, LifeLabs has had 0 fatalities and 0 cases of recordable work-related ill health.

Work-related hazards related to ill-health come from interacting with patients who may have communicable diseases and with the lab specimens provided by these patients. Risk assessments for patients and for lab samples have been conducted. Controls to reduce risk if illness included use of biosafety cabinets, safety engineered medical devices, shielding, training and SOPs, workstation layout, and personal protective equipment.

GRI 404: Training 
404-1 – Average hours of training per year per employee As of December 2020, the average hours of training per employee in 2020 was 27.5 hours. This includes online and in-person training hours tracked in our company-wide learning management system.
Leaders completed additional leadership development training hours for an average of 3 hours per people leader (450 leaders, including individual contributors, as of Dec 2020)
404-2 – Programs for upgrading employee skills and transition assistance programs

LifeLabs uses Performance Management as a process that involves setting business goals and personal development plans (as appropriate), monitoring progress / on-going coaching and feedback and the annual performance review.

We have a wide range of development offerings to support upgrading of employee skills including:

  • Senior Leadership Learning Sessions
  • Leading Through COVID facilitated sessions by Morneau Shepell
  • Leading @ LifeLabs, a leadership development program for managers, supervisors, and individual contributors
  • Diversity, Equity & Inclusion (DEI) facilitated sessions
  • MyPerformance online learning program on performance management at LifeLabs.
  • Competency training and assessments
  • Customer Experience Transformation Program for Client Services
  • LearningLabs online webinars from industry experts
  • College of American Pathologists online learning
404-3 – Percentage of employees receiving regular performance and career development reviews

Percentage of employees at year-end, who received a regular performance/career development review by gender and employee category*:

  • Female: 3,965, 61%
  • Male: 1,203, 18%
  • Full-Time: 3002, 46%
  • Part-Time: 492, 8%
  • PT Regular: 1525, 23%
  • Casual: 147, 2%
  • Temporary: 2, 0.03%

* Employees would not receive a review if they are: on leave during the year and not worked for 3 months, a new hire, a temp, a union employee.

Diversity and Equal Opportunity
GRI 405: Diversity and Equal Opportunity
405-1 – Diversity of governance bodies and employees

Percentage of individuals within the organization’s governance bodies (ELT) by number & percentage:

  • Female: 5, 50%
  • Male: 5, 50%

Number & percentage of employees in a leadership role (director level and above):

  • Female: 22, 44%
  • Male: 28, 56%

Number & percentage of employees by gender

  • Female: 5072, 77%
  • Male: 1479, 23%
Human Rights Assessment 
GRI 412: Human Rights Assessment 
412 -2 – Employee training on human rights policies or procedures LifeLabs is unable to pull this data with the current systems, however we are working with our Human Resources and Legal teams to redesign and amplify our disclosure on employee training on human rights policies and procedures. In 2020, LifeLabs also began offering Labour Relations training for people leaders.
Local Communities 
GRI 413: Local Communities 
413-1 – Operations with local community engagement, impact assessments, and development programs

LifeLabs hosts PJ day with carnival games for kids with cancer –

LifeLabs looked very comfy for this year’s Pajama Day –

Supplier Social Assessment
GRI 414: Supplier Social Assessment
414-1 – New suppliers that were screened using social criteria LifeLabs does not report specific numbers or percentages related to social screening, however our procurement processes do include specific social criteria against which suppliers are assessed.
Customer Health & Safet
GRI 416: Customer Health & Safet
416-2 – Incidents of non-compliance concerning the health and safety impacts of products and services No warnings, penalties, or fines were issued concerning the health and safety impacts of our products and services
Marketing and Labeling
GRI 417: Marketing and Labeling
417-1 – Requirements for product and service information and labelling LifeLabs offers services and does not manufacture or distribute products. Therefore this is not relevant to our organization.
Socioeconomic Compliance
GRI 419: Socioeconomic Compliance
419-1 – Non compliance with laws and regulations in the social and economic area In 2020 we did not pay any fines related to non-compliance with laws and regulations in the social and economic area.